For example, CRISPR-based targeted integration of a CD19 CAR into the TRAC locus with adeno-associated virus 6 (AAV6) resulted in uniform CAR expression, the enhanced in vitro and in vivo anti-tumor function of CAR T cells, and simultaneous elimination of endogenous TCR specificities [240]. Here, CD19 is linked to neoplasm.